Affordable Access

Publisher Website

Etretinate therapy reduces inpatient treatment of psoriasis

Authors
Journal
Journal of the American Academy of Dermatology
0190-9622
Publisher
Elsevier
Publication Date
Volume
17
Issue
5
Identifiers
DOI: 10.1016/s0190-9622(87)70264-3
Disciplines
  • Economics
  • Medicine

Abstract

Abstract Twenty-six patients with a history of hospitalization for severe psoriasis were evaluated with regard to their use of inpatient therapy before and during therapy with etretinate. The duration of the pretherapy period and the etretinate treatment period averaged 5 and 4 years, respectively. Use of etretinate nearly eliminated inpatient therapy among these patients. Twelve of the patients stopped etretinate; their use of hospitalization for psoriasis remained below pre-etretinate levels in the two years after etretinate therapy was stopped. Etretinate therapy represents an effective and economical alternative to hospitalization for psoriasis treatment.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

Etretinate therapy reduces inpatient treatment of...

on Journal of the American Academ... November 1987

Etretinate therapy reduces inpatient treatment of...

on Journal of the American Academ... Jan 01, 1988

Treatment of psoriasis: day care vs. inpatient the...

on British Journal of Dermatology February 1999

[Treatment of therapy resistant forms of psoriasis...

on Dermatologische Monatschrift 1988
More articles like this..